Le Lézard
Classified in: Health
Subject: CHI

AdventHealth Hospital Successfully Completes Craniosynostosis Surgery Utilizing Cutting-edge VisAR Augmented Reality Surgical Navigation


SALT LAKE CITY, Jan. 16, 2024 /PRNewswire/ -- AdventHealth for Children, a nationally recognized children's hospital and network of pediatric specialists based in Central Florida, recently performed the successful completion of a cranial vault remodeling for craniosynostosis utilizing the VisAR augmented reality surgical navigation system. The surgery, performed to correct a child's misshapen skull, highlights the use of augmented reality (AR) as an effective guide during complex surgeries.

Craniosynostosis is a congenital condition in which an infant's skull bones fuse prematurely, resulting in an abnormal head shape and potential developmental issues. The surgical team at AdventHealth for Children, led by chief of pediatric reconstructive surgery, Dr. Raj Sawh-Martinez, harnessed the capabilities of VisAR surgical navigation during surgery and compared a more conventional approach using 3D printed templates. The VisAR system projected the planned surgical cuts needed to correct the deformity through the VisAR heads up display onto the surface of the child's skull, which were then marked with a surgical marker.

VisAR provided real-time, three-dimensional visualization of the patient's anatomy during the operation, as well as enhanced precision and accuracy. Traditional craniosynostosis surgery requires multiple highly involved steps to complete. AR technology promises to allow surgeons to navigate the complex correctional cuts with detailed visualization, simplifying the surgery as a whole.

Craniosynostosis surgery is typically performed either free hand or using 3D-printed guides to assist the surgeon in marking and reconstructing a child's skull. When comparing AR navigation to the 3D-printed guide, Dr. Raj Sawh-Martinez commented: "The functionality and precision of this new technology is incredible. AR navigation is the holy grail for these types of surgeries, and we're so excited to be able to offer it to patients and families and make lasting impacts in the lives of children with craniofacial conditions." 

VisAR offers real-time superimposition in 3D space of the patients preoperative MR or CT and patient-specific anatomical overlays. It has been used in an array of surgical disciplines throughout the world, including spine, neurosurgery, orthopedics, interventional radiology, and plastic surgery. Its applications continue to expand.

VisAR has been used for surgery in 8 different countries, is FDA-cleared for stereotactic spinal surgery, and is currently available for purchase in the United States, Mexico, and Indonesia. A cranial indication is pending with the FDA.

About Novarad Corporation

Novarad is a global healthcare technology company specializing in the development and deployment of innovative medical imaging and informatics solutions.

Learn more about its revolutionary VisAR augmented reality surgical navigation system at novarad.net/visar.

About AdventHealth for Children 

AdventHealth for Children is a nationally recognized children's hospital and network of pediatric specialists, programs and care facilities that sets the standard for innovation, quality and comprehensive care.

The AdventHealth for Children care network includes more than 250 pediatricians and pediatric specialists practicing 35 subspecialties, community specialty clinics, pediatric rehabilitation, pediatric emergency rooms and Centra Care Kids urgent care.

AdventHealth for Children is one of the nation's best and safest children's hospitals, ranked as a Top Children's Hospital by the Leapfrog Group, a three-time gold standard Magnet designated hospital by the ANCC, and recognized by U.S. News & World Report as a national leader in newborn care.

SOURCE Novarad Corporation


These press releases may also interest you

at 20:33
Report with market evolution powered by AI - The global pharmaceuticals wholesale and distribution market  size is estimated to grow by USD 896.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45% ...

at 20:22
Report on how AI is redefining market landscape - The global health and wellness food market size is estimated to grow by USD 627.6 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 9.8% during the forecast...

at 20:17
Report with market evolution powered by AI - The fundus camera market and it is set to grow by USD 174.65 thousand from 2025 to 2029. However, the growth momentum will progressing at a CAGR of over 6.2% during the forecast period, according to...

at 20:00
On 12 Feb 2025 (Singapore Time), Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an international multicenter Phase...

at 19:50
Oqory, Inc., a private biopharmaceutical company dedicated to developing next-generation antibody drug conjugates (ADCs) for the treatment of cancer, today announced that Michael King, Chief Executive Officer, will present data at Oppenheimer's 35th...

at 18:59
The news release, U.S. FDA approves Celltrion's AVTOZMA® (tocilizumab-anoh), a biosimilar to ACTEMRA®, issued 30-Jan-2025 by Celltrion over PR Newswire, has been updated to ensure accuracy of the availability timing of AVTOZMA® (CT-P47,...



News published on and distributed by: